Company intelligence / Profile preview
Evolved By Nature
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
Evolved By Nature develops sustainable biomolecules using its proprietary Activated Silk™ technology derived from natural silk protein. The company has launched commercial products in personal care and beauty sectors while advancing preclinical research into regenerative medicine, rare dermatological disorders, and orphan disease therapeutics. Its peptide platform offers biocompatible alternatives to petrochemical ingredients with demonstrated barrier-enhancing properties for both medical and consumer product applications.
- Therapeutic areas
- Rare DiseasesDermatologyOphthalmology
- Modalities
- Peptides (specifically silk-derived peptides and polypeptides)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Evolved By Nature.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evolved By Nature.